Cargando…

A Nomogram Prognostic Model for Advanced Hepatocellular Carcinoma Based on the Interaction Between CD8(+)T Cell Counts and Age

OBJECTIVE: CD8(+)T cells are essential components of the adaptive immune system and are crucial in the body’s immune system. This study aimed to investigate how the prognosis of patients with advanced hepatocellular carcinoma (HCC) was affected by their CD8(+) T cell counts and age and established a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yuan, Liu, Xiaoli, Wang, Xinhui, Yu, Lihua, Yan, Huiwen, Xie, Yuqing, Pu, Qing, Cai, Xue, Kong, Yaxian, Yang, Zhiyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519212/ https://www.ncbi.nlm.nih.gov/pubmed/37752911 http://dx.doi.org/10.2147/OTT.S426195

Ejemplares similares

Establishment of Nomogram Model for Minimally Invasive Treatment of Small Hepatocellular Carcinoma Based on CD8(+)T Cell Counts
por: Pu, Qing, et al.
Publicado: (2022)

Glycometabolism-related gene signature of hepatocellular carcinoma predicts prognosis and guides immunotherapy
por: Yu, Lihua, et al.
Publicado: (2022)

A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy
por: Zhou, Dongdong, et al.
Publicado: (2021)

Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma
por: Xie, Yuqing, et al.
Publicado: (2022)

Dynamic Nomogram for Predicting Macrovascular Invasion of Patients with Unresectable Hepatocellular Carcinoma after Transarterial Chemoembolization
por: Yan, Huiwen, et al.
Publicado: (2022)

Immunomodulatory Effect of Traditional Chinese Medicine Combined with Systemic Therapy on Patients with Liver Cancer: A Systemic Review and Network Meta-analysis
por: Pu, Qing, et al.
Publicado: (2022)

The survival strength of younger patients in BCLC stage 0-B of hepatocellular carcinoma: basing on competing risk model
por: Yan, Huiwen, et al.
Publicado: (2022)

Antiviral Therapy Reduces Mortality in Hepatocellular Carcinoma Patients with Low-Level Hepatitis B Viremia
por: Wang, Xinhui, et al.
Publicado: (2021)

Primary non-response to antiviral therapy affects the prognosis of hepatitis B virus-related hepatocellular carcinoma
por: Wang, Peng, et al.
Publicado: (2023)

Impact of gender as a prognostic factor in HBV-related Hepatocellular Carcinoma: the survival strength of female patients in BCLC stage 0-B
por: Yu, Lihua, et al.
Publicado: (2019)

A Novel Prognostic Score Based on Artificial Intelligence in Hepatocellular Carcinoma: A Long-Term Follow-Up Analysis
por: Liu, Xiaoli, et al.
Publicado: (2022)

Use of a Novel Thyroid-Stimulating Hormone Model for Predicting the Progression of Hepatocellular Carcinoma
por: Yu, Lihua, et al.
Publicado: (2020)

Nucleos(t)ide Analogues for Reducing Hepatocellular Carcinoma in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis
por: Wang, Xinhui, et al.
Publicado: (2020)

Molecular targets of Yangyin Fuzheng Jiedu Prescription in the treatment of hepatocellular carcinoma based on network pharmacology analysis
por: Yan, Fengna, et al.
Publicado: (2020)

Prognostic Nomogram for Advanced Hepatocellular Carcinoma Treated with FOLFOX 4
por: Qin, Shukui, et al.
Publicado: (2017)

Morbidity, Prognostic Factors, and Competing Risk Nomogram for Combined Hepatocellular-Cholangiocarcinoma
por: Chen, Xiaoyuan, et al.
Publicado: (2021)

Long terms trends in CD4(+) cell counts, CD8(+) cell counts, and the CD4(+) : CD8(+) ratio
por: Hughes, Rachael A., et al.
Publicado: (2018)

TIGIT(+) TIM-3(+) NK cells are correlated with NK cell exhaustion and disease progression in patients with hepatitis B virus‑related hepatocellular carcinoma
por: Yu, Lihua, et al.
Publicado: (2021)

Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma
por: Hu, Chuan, et al.
Publicado: (2020)

High Levels of CD244 Rather Than CD160 Associate With CD8(+) T-Cell Aging
por: Wang, Xinyue, et al.
Publicado: (2022)

Prognostic Significance of CSN2, CD8, and MMR Status-Associated Nomograms in Patients with Colorectal Cancer
por: Zhu, Bing, et al.
Publicado: (2018)

Effect of serum triglyceride level on the prognosis of patients with hepatocellular carcinoma in the absence of cirrhosis
por: Liu, Xiaoli, et al.
Publicado: (2018)

Status and prognostic nomogram of patients with Burkitt lymphoma
por: Lu, Jielun, et al.
Publicado: (2020)

Development and Validation of a Prognostic Nomogram in AFP-negative hepatocellular carcinoma
por: Wang, Xueping, et al.
Publicado: (2019)

Development and validation of prognostic nomograms for large hepatocellular carcinoma after HAIC
por: Yao, Wang, et al.
Publicado: (2023)

White Blood Count, Albumin, and BMI Enhance VACS Index Prognostic Model, but Nadir CD4 and CD8 Metrics Do Not
por: Tate, Janet P, et al.
Publicado: (2017)

CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort Study
por: Chammartin, Frédérique, et al.
Publicado: (2022)

Peripheral blood CD4+ cell counts but not CD3+ and CD8+ cell counts are reduced in SARS-CoV-2 infection
por: Huang, Zhi-Xin, et al.
Publicado: (2020)

Clinicopathologic and prognostic significance of tumor-infiltrating CD8+ T cells in patients with hepatocellular carcinoma: A meta-analysis
por: Xu, Xuezhong, et al.
Publicado: (2019)

Prognostic nomogram for hepatocellular carcinoma in adolescent and young adult patients after hepatectomy
por: Zhang, Wei, et al.
Publicado: (2017)

Development of a Novel Autophagy-Related Prognostic Signature and Nomogram for Hepatocellular Carcinoma
por: Fang, Qiongxuan, et al.
Publicado: (2020)

Prognostic nomogram for hepatocellular carcinoma with radiofrequency ablation: a retrospective cohort study
por: Lu, Zhenhua, et al.
Publicado: (2021)

Diagnostic and Prognostic Nomograms for Hepatocellular Carcinoma Based on PIVKA-II and Serum Biomarkers
por: An, Shu, et al.
Publicado: (2023)

CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus–Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC)
por: Trickey, Adam, et al.
Publicado: (2017)

Intratumoral and peritumoral expression of CD68 and CD206 in hepatocellular carcinoma and their prognostic value
por: Ren, Chun-Xia, et al.
Publicado: (2017)

Development and validation of a prognostic nomogram for IgA nephropathy
por: Liu, Jian, et al.
Publicado: (2017)

CD4+T, CD8+T counts and severe COVID-19: A meta-analysis
por: Zhang, Haipeng, et al.
Publicado: (2020)

Prognostic Nomogram For Locoregionally Advanced Nasopharyngeal Carcinoma
por: Jiang, Yanming, et al.
Publicado: (2020)

A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study
por: Marasco, Giovanni, et al.
Publicado: (2021)

The Prognostic Value of Platelet Count in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Pang, Qing, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v64haj39qhbc406424jdmeojvj